Impax to Present at the 24th Annual Credit Suisse Healthcare Conference

November 5, 2015

HAYWARD, Calif., Nov. 5, 2015 /PRNewswire/ --Impax Laboratories, Inc. (NASDAQ: IPXL) invites investors and the general public to listen to a webcast of a presentation at the 24th Annual Credit Suisse Healthcare Conference on Wednesday, November 11, 2015 at 1:30 p.m. Mountain Standard Time.

Logo -

Individuals may listen to the live or an archived presentation made at the conference, which will be posted in the investor relations section of the Company's web site at

About Impax Laboratories, Inc.

Impax Laboratories, Inc. (Impax) is a specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of central nervous system disorder branded products. Impax markets its generic products through its Impax Generics division and markets its branded products through the Impax Specialty Pharma division. Additionally, where strategically appropriate, Impax develops marketing partnerships to fully leverage its technology platform and pursues partnership opportunities that offer alternative dosage form technologies, such as injectables, nasal sprays, inhalers, patches, creams and ointments. For more information, please visit the Company's Web site at:

Company Contacts:                                                 
Mark Donohue
Investor Relations and Corporate Communications       
(215) 558-4526                                                  

To view the original version on PR Newswire, visit:

SOURCE Impax Laboratories, Inc.